SREBP-1 Transcription Factors Regulate Skeletal Muscle Cell Size by Controlling Protein Synthesis through Myogenic Regulatory Factors

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Dessalle, Kevin ^a   Euthine, Vanessa ^a   Chanon, Stéphanie ^a   Delarichaudy, Joffrey ^a   Fujii, Isao ^b   Rome, Sophie ^a   Vidal, Hubert ^a   Nemoz, Georges ^a   Simon, Chantal ^a   Lefai, Etienne ^a  

^a UNIVERSITÉ LYON 1   (France)

^b SOJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MYOGENIC FACTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ARTICLE; CELL SIZE; DOWN REGULATION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MUSCLE CELL; MUSCLE MASS; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SKELETAL MUSCLE;

CELL SIZE; HUMANS; MADS DOMAIN PROTEINS; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOD PROTEIN; MYOGENIC REGULATORY FACTORS; MYOGENIN; PROTEIN BIOSYNTHESIS; PROTEOLYSIS; RNA, SMALL INTERFERING; SARCOMERES; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84870604901     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050878     Document Type: Article

References (42)

1. Evans WJ, (2010) Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr 91: 1123S-1127S.
2. Lecomte V, Meugnier E, Euthine V, Durand C, Freyssenet D, et al. (2010) A new role for sterol regulatory element binding protein 1 transcription factors in the regulation of muscle mass and muscle cell differentiation. Mol Cell Biol 30: 1182-1198.
3. Horton JD, (2002) Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem Soc Trans 30: 1091-1095.
4. Raghow R, Yellaturu C, Deng X, Park EA, Elam MB, (2008) SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 19: 65-73.
5. Ducluzeau PH, Perretti N, Laville M, Andreelli F, Vega N, et al. (2001) Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Diabetes 50: 1134-1142.
6. Guillet-Deniau I, Mieulet V, Le Lay S, Achouri Y, Carre D, et al. (2002) Sterol regulatory element binding protein-1c expression and action in rat muscles: insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression. Diabetes 51: 1722-1728.
7. Dif N, Euthine V, Gonnet E, Laville M, Vidal H, et al. (2006) Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs. Biochem J 400: 179-188.
8. Boonsong T, Norton L, Chokkalingam K, Jewell K, Macdonald I, et al. (2007) Effect of exercise and insulin on SREBP-1c expression in human skeletal muscle: potential roles for the ERK1/2 and Akt signalling pathways. Biochem Soc Trans 35: 1310-1311.
9. Kotzka J, Muller-Wieland D, Roth G, Kremer L, Munck M, et al. (2000) Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade. J Lipid Res 41: 99-108.
10. Nadeau KJ, Leitner JW, Gurerich I, Draznin B, (2004) Insulin regulation of sterol regulatory element-binding protein-1 expression in L-6 muscle cells and 3T3 L1 adipocytes. J Biol Chem 279: 34380-34387.
11. Kallin A, Johannessen LE, Cani PD, Marbehant CY, Essaghir A, et al. (2007) SREBP-1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55 gamma. J Lipid Res 48: 1628-1636.
12. Im SS, Hammond LE, Yousef L, Nugas-Selby C, Shin DJ, et al. (2009) Sterol regulatory element binding protein 1a regulates hepatic fatty acid partitioning by activating acetyl coenzyme A carboxylase 2. Mol Cell Biol 29: 4864-4872.
13. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, et al. (2003) Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A 100: 12027-12032.
14. Maxwell KN, Soccio RE, Duncan EM, Sehayek E, Breslow JL, (2003) Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J Lipid Res 44: 2109-2119.
15. Rome S, Lecomte V, Meugnier E, Rieusset J, Debard C, et al. (2008) Microarray analyses of SREBP-1a and SREBP-1c target genes identify new regulatory pathways in muscle. Physiol Genomics 34: 327-337.
16. Abiola M, Favier M, Christodoulou-Vafeiadou E, Pichard AL, Martelly I, et al. (2009) Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells. PLoS One 4: e8509.
17. Edmondson DG, Olson EN, (1993) Helix-loop-helix proteins as regulators of muscle-specific transcription. J Biol Chem 268: 755-758.
18. Kitzmann M, Carnac G, Vandromme M, Primig M, Lamb NJ, et al. (1998) The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells. J Cell Biol 142: 1447-1459.
19. Hughes SM, Taylor JM, Tapscott SJ, Gurley CM, Carter WJ, et al. (1993) Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development 118: 1137-1147.
20. Hughes SM, Koishi K, Rudnicki M, Maggs AM, (1997) MyoD protein is differentially accumulated in fast and slow skeletal muscle fibres and required for normal fibre type balance in rodents. Mech Dev 61: 151-163.
21. Walters EH, Stickland NC, Loughna PT, (2000) The expression of the myogenic regulatory factors in denervated and normal muscles of different phenotypes. J Muscle Res Cell Motil 21: 647-653.
22. Ishido M, Kami K, Masuhara M, (2004) In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle. Am J Physiol Cell Physiol 287: C484-493.
23. Ishido M, Kami K, Masuhara M, (2004) Localization of MyoD, myogenin and cell cycle regulatory factors in hypertrophying rat skeletal muscles. Acta Physiol Scand 180: 281-289.
24. Cozzone D, Debard C, Dif N, Ricard N, Disse E, et al. (2006) Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells. Diabetologia 49: 990-999.
25. De Larichaudy J, Zufferli A, Serra F, Isidori AM, Naro F, et al. (2012) TNFalpha- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism. Skelet Muscle 2: 2.
26. Fujii I, Matsukura M, Ikezawa M, Suzuki S, Shimada T, et al. (2006) Adenoviral mediated MyoD gene transfer into fibroblasts: myogenic disease diagnosis. Brain Dev 28: 420-425.
27. Gulve EA, Dice JF, (1989) Regulation of protein synthesis and degradation in L8 myotubes. Effects of serum, insulin and insulin-like growth factors. Biochem J 260: 377-387.
28. Amemiya-Kudo M, Shimano H, Hasty AH, Yahagi N, Yoshikawa T, et al. (2002) Transcriptional activities of nuclear SREBP-1a,-1c, and-2 to different target promoters of lipogenic and cholesterogenic genes. J Lipid Res 43: 1220-1235.
29. Macpherson PC, Wang X, Goldman D, (2011) Myogenin regulates denervation-dependent muscle atrophy in mouse soleus muscle. J Cell Biochem 112: 2149-2159.
30. Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, et al. (2010) Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 143: 35-45.
31. Charge SB, Brack AS, Bayol SA, Hughes SM, (2008) MyoD- and nerve-dependent maintenance of MyoD expression in mature muscle fibres acts through the DRR/PRR element. BMC Dev Biol 8: 5.
32. Li H, Capetanaki Y, (1993) Regulation of the mouse desmin gene: transactivated by MyoD, myogenin, MRF4 and Myf5. Nucleic Acids Res 21: 335-343.
33. Merlie JP, Mudd J, Cheng TC, Olson EN, (1994) Myogenin and acetylcholine receptor alpha gene promoters mediate transcriptional regulation in response to motor innervation. J Biol Chem 269: 2461-2467.
34. Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, et al. (2009) Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS One 4: e4973.
35. Bruusgaard JC, Egner IM, Larsen TK, Dupre-Aucouturier S, Desplanches D, et al. (2012) No change in myonuclear number during muscle unloading and reloading. J Appl Physiol 113: 290-296.
36. Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, et al. (2011) mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146: 408-420.
37. Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, et al. (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 8: 224-236.
38. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, et al. (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13: 376-388.
39. Ponugoti B, Kim DH, Xiao Z, Smith Z, Miao J, et al. (2010) SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem 285: 33959-33970.
40. Walker AK, Yang F, Jiang K, Ji JY, Watts JL, et al. (2010) Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev 24: 1403-1417.
41. Sewter C, Berger D, Considine RV, Medina G, Rochford J, et al. (2002) Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha. Diabetes 51: 1035-1041.
42. Commerford SR, Peng L, Dube JJ, O'Doherty RM, (2004) In vivo regulation of SREBP-1c in skeletal muscle: effects of nutritional status, glucose, insulin, and leptin. Am J Physiol Regul Integr Comp Physiol 287: R218-227.